Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Foster

Showing results (1231-1240 of 1,323) with videos related to

Pageof 133
Sort By:
Alcoholism, Clinical and Experimental Research|September 1, 2005
Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcoholJason B Cook, Katrina L Foster, William J A Eiler, et al.
Nature Methods|May 27, 2026
External validation improves generalizability, replicability and reproducibility in predictive models for neuroimagingMatthew Rosenblatt, Maya L Foster, Brendan D Adkinson, et al.
Nature Communications|May 17, 2019
More efficient North Atlantic carbon pump during the Last Glacial MaximumJ Yu, L Menviel, Z D Jin, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?D A Messner, P Rabins, A C Downing, et al.
Nature Communications|March 20, 2026
The relative role of direct orbital forcing versus CO<sub>2</sub> and ice feedbacks on Quaternary climateC J R Williams, N S Lord, A T Kennedy-Asser, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
International Journal of Molecular Sciences|January 8, 2023
Childhood Hypophosphatasia Associated with a Novel Biallelic <i>ALPL</i> Variant at the TNSALP Dimer InterfaceLuciane Martins, Luis Gustavo F Lessa, Taccyanna M Ali, et al.
Journal of Internal Medicine|July 9, 2019
Profiling of how nociceptor neurons detect danger - new and old foesT Crosson, K Roversi, M Balood, et al.
Scientific Reports|February 5, 2024
Elevated body temperature is associated with depressive symptoms: results from the TemPredict StudyAshley E Mason, Patrick Kasl, Severine Soltani, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Pageof 133

Showing results (1231-1240 of 1,323) with videos related to

Sort By:
Pageof 133
Alcoholism, Clinical and Experimental Research|September 1, 2005
Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcoholJason B Cook, Katrina L Foster, William J A Eiler, et al.
Nature Methods|May 27, 2026
External validation improves generalizability, replicability and reproducibility in predictive models for neuroimagingMatthew Rosenblatt, Maya L Foster, Brendan D Adkinson, et al.
Nature Communications|May 17, 2019
More efficient North Atlantic carbon pump during the Last Glacial MaximumJ Yu, L Menviel, Z D Jin, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?D A Messner, P Rabins, A C Downing, et al.
Nature Communications|March 20, 2026
The relative role of direct orbital forcing versus CO<sub>2</sub> and ice feedbacks on Quaternary climateC J R Williams, N S Lord, A T Kennedy-Asser, et al.
Research Square|June 12, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
International Journal of Molecular Sciences|January 8, 2023
Childhood Hypophosphatasia Associated with a Novel Biallelic <i>ALPL</i> Variant at the TNSALP Dimer InterfaceLuciane Martins, Luis Gustavo F Lessa, Taccyanna M Ali, et al.
Journal of Internal Medicine|July 9, 2019
Profiling of how nociceptor neurons detect danger - new and old foesT Crosson, K Roversi, M Balood, et al.
Scientific Reports|February 5, 2024
Elevated body temperature is associated with depressive symptoms: results from the TemPredict StudyAshley E Mason, Patrick Kasl, Severine Soltani, et al.
Addiction Science & Clinical Practice|October 31, 2025
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocolChristopher S Freet, Kirsten Shuler, Sarah Kawasaki, et al.
Pageof 133